257 related articles for article (PubMed ID: 14711364)
1. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
Fernández LE; Alonso DF; Gomez DE; Vázquez AM
Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
3. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
4. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
[TBL] [Abstract][Full Text] [Related]
5. NGcGM3 ganglioside: a privileged target for cancer vaccines.
Fernandez LE; Gabri MR; Guthmann MD; Gomez RE; Gold S; Fainboim L; Gomez DE; Alonso DF
Clin Dev Immunol; 2010; 2010():814397. PubMed ID: 21048926
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotype antibodies in cancer treatment.
de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody.
Talavera A; Eriksson A; Okvist M; López-Requena A; Fernández-Marrero Y; Pérez R; Moreno E; Krengel U
Mol Immunol; 2009 Oct; 46(16):3466-75. PubMed ID: 19748674
[TBL] [Abstract][Full Text] [Related]
8. Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody.
Chapman PB
Curr Opin Investig Drugs; 2003 Jun; 4(6):710-5. PubMed ID: 12901230
[TBL] [Abstract][Full Text] [Related]
9. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
Bendandi M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):65-72. PubMed ID: 12113135
[TBL] [Abstract][Full Text] [Related]
10. [Past, present and future of anti-idiotype vaccination].
Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype system.
López-Requena A; De Acosta CM; Moreno E; González M; Puchades Y; Talavera A; Vispo NS; Vázquez AM; Pérez R
Mol Immunol; 2007 Jan; 44(4):423-33. PubMed ID: 16581129
[TBL] [Abstract][Full Text] [Related]
13. Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Bhattachary-Chatterjee M; Nath Baral R; Chatterjee SK; Das R; Zeytin H; Chakraborty M; Foon KA
Cancer Immunol Immunother; 2000 Jun; 49(3):133-41. PubMed ID: 10881692
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
15. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
16. Antigens for cancer immunotherapy.
Neller MA; López JA; Schmidt CW
Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
[TBL] [Abstract][Full Text] [Related]
17. Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
Euhus DM; Wong JH
Surg Gynecol Obstet; 1992 Jul; 175(1):89-96. PubMed ID: 1621207
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial.
Neninger E; Díaz RM; de la Torre A; Rives R; Díaz A; Saurez G; Gabri MR; Alonso DF; Wilkinson B; Alfonso AM; Combet T; Pérez R; Vázquez AM
Cancer Biol Ther; 2007 Feb; 6(2):145-50. PubMed ID: 17218777
[TBL] [Abstract][Full Text] [Related]
19. Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer.
Gajdosik Z
Drugs Today (Barc); 2014 Apr; 50(4):301-7. PubMed ID: 24918647
[TBL] [Abstract][Full Text] [Related]
20. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
Brockstedt DG; Dubensky TW
Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
